Roche NimbleGen, Inc.
Roche NimbleGen, Inc., a subsidiary of Roche Diagnostics, is a leading player in the biotechnology industry, headquartered in the United States. Founded in 2000, the company has established itself as a pioneer in the development of advanced genomic solutions, particularly in the fields of microarray technology and next-generation sequencing. With a focus on high-resolution genomic analysis, Roche NimbleGen offers a range of core products, including custom microarrays and innovative sequencing solutions. These products are distinguished by their exceptional sensitivity and specificity, catering to researchers in genomics, cancer research, and personalised medicine. Roche NimbleGen's commitment to innovation has positioned it as a trusted partner in the life sciences sector, contributing significantly to advancements in genetic research and diagnostics. The company continues to achieve notable milestones, reinforcing its reputation as a leader in genomic technologies.
DitchCarbon Score
How does Roche NimbleGen, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Roche NimbleGen, Inc.'s score of 83 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Roche NimbleGen, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. As a current subsidiary of Roche Holding AG, any climate commitments or emissions data would be inherited from its parent company. Roche Holding AG has set ambitious climate targets, which may influence Roche NimbleGen's sustainability initiatives. However, specific reduction targets or achievements for Roche NimbleGen are not detailed in the available information. The company is part of a broader corporate family that is committed to addressing climate change, but without specific emissions data or reduction initiatives outlined for Roche NimbleGen, it is challenging to provide a comprehensive overview of its carbon footprint or climate commitments. In summary, while Roche NimbleGen is aligned with the sustainability goals of its parent company, Roche Holding AG, specific emissions data and reduction targets for Roche NimbleGen remain unspecified.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 403,136,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 188,924,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Roche NimbleGen, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
